Digitalis in the Management of Heart Failure
作者:
SmithThomas W.,
期刊:
Hospital Practice
(Taylor Available online 1984)
卷期:
Volume 19,
issue 3
页码: 67-92
ISSN:2154-8331
年代: 1984
DOI:10.1080/21548331.1984.11702768
出版商: Taylor&Francis
数据来源: Taylor
摘要:
After 200 years in which digitalis has been the key drug in the pharmacotherapy of cardiac failure, there is now beginning to emerge a body of evidence suggesting which patients will respond—both symptomatically and in ventricular function—to the cardiac glycoside. A patient with low cardiac output and lack of cardiac reserve should benefit most.
点击下载:
PDF (2332KB)
返 回